Rocket Pharmaceuticals Inc (NASDAQ: RCKT) on Friday, plunged -3.79% from the previous trading day, before settling in for the closing price of $3.17. Within the past 52 weeks, RCKT’s price has moved between $2.19 and $15.95.
Healthcare Sector giant saw their annual sales slid by -11.60% over the last five years. The company achieved an average annual earnings per share of 24.69%. With a float of $98.98 million, this company’s outstanding shares have now reached $108.21 million.
Rocket Pharmaceuticals Inc (RCKT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rocket Pharmaceuticals Inc is 8.54%, while institutional ownership is 87.54%. The most recent insider transaction that took place on Oct 14 ’25, was worth 114,581. In this transaction an insider of this company sold 28,918 shares at a rate of $3.96, taking the stock ownership to the 67,006 shares. Before that another transaction happened on Oct 14 ’25, when Company’s Officer proposed sale 28,918 for $3.96, making the entire transaction worth $114,581.
Rocket Pharmaceuticals Inc (RCKT) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.62 earnings per share (EPS) for the period topping the consensus outlook (set at -0.72) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.68% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Rocket Pharmaceuticals Inc (RCKT) is currently performing well based on its current performance indicators. A quick ratio of 7.30 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Analysing the last 5-days average volume posted by the [Rocket Pharmaceuticals Inc, RCKT], we can find that recorded value of 2.17 million was lower than the volume posted last year of 3.4 million. As of the previous 9 days, the stock’s Stochastic %D was 20.42%.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 30.82%, which indicates a significant increase from 3.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.43, while its 200-day Moving Average is $5.07. Now, the first resistance to watch is $3.19. This is followed by the second major resistance level at $3.34. The third major resistance level sits at $3.42. If the price goes on to break the first support level at $2.96, it is likely to go to the next support level at $2.88. Now, if the price goes above the second support level, the third support stands at $2.73.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
Market capitalization of the company is 330.08 million based on 108,222K outstanding shares. Right now, sales total 0 K and income totals -258,750 K. The company made 0 K in profit during its latest quarter, and -50,330 K in sales during its previous quarter.
